Milk thistle has been used for liver complaints across Mediterranean and later broader European herbal medicine for over two thousand years, with ancient Greek and Roman physicians documenting its use. Its name derives from the milky white veins on its leaves, which folklore attributed to the Virgin Mary's milk.
Modern research has concentrated on silymarin, milk thistle's primary active compound complex, testing it specifically for liver protection across a genuinely wide range of distinct liver conditions.
Milk thistle has real, condition-specific evidence rather than a single blanket "liver herb" effect. For preventing drug-induced liver injury, a meta-analysis of 5 RCTs (1,198 patients) found silymarin significantly reduced the occurrence of anti-tuberculosis drug-induced liver injury, along with significant improvements in liver enzyme markers. A separate, larger meta-analysis of 26 RCTs (2,375 patients) examined silymarin for nonalcoholic fatty liver disease and found genuine therapeutic benefit.
The important, differentiating caveat: for chronic hepatitis C specifically, a meta-analysis of 5 trials (389 patients) found no significant difference between silymarin and placebo on viral RNA levels, liver enzymes, or quality of life — a clear negative finding despite milk thistle's broad popular reputation as a general "liver detox" herb. This condition-specific pattern is a more accurate picture than a blanket claim, which is why "Moderate" is the accurate rating.
Seeds crushed and prepared as tea or tincture; modern research uses standardized silymarin extract, given the compound's poor natural water solubility.